Objective: Increased respiratory muscle work is associated with dyspnea and poor exercise tolerance in obese patients. We evaluated the effect of respiratory muscle endurance training (RMET) on respiratory muscle capacities, symptoms and exercise capacity in obese patients. Design: A total of 20 obese patients hospitalized for 26 ± 6 days to follow a low-calorie diet and a physical activity program were included in this case-control study. Of them, 10 patients performed RMET (30-min isocapnic hyperpnea at 60-80% maximum voluntary ventilation, 3-4 times per week during the whole hospitalization period: RMET group), while the other 10 patients performed no respiratory training (control (CON) group). RMET and CON groups were matched for body mass index (BMI) (45 ± 7 kg m À2 ) and age (42 ± 12 years). Lung function, respiratory muscle strength and endurance, 6-min walking distance, dyspnea (Medical Research Council scale) and quality of life (short-form health survey 36 questionnaire) were assessed before and after intervention. Results: Similar BMI reduction was observed after hospitalization in the RMET and CON groups (À2±1 kg m À2 , Po0.001). No significant change in lung function and respiratory muscle strength was observed except for vital capacity, which increased in the RMET group ( þ 0.20±0.26 l, P ¼ 0.039). Respiratory muscle endurance increased in the RMET group only ( þ 52±27%, Po0.001). Compared with the CON group, the RMET group had greater improvement in 6MWT ( þ 54 ± 35 versus þ 1 ± 7 m, P ¼ 0.007), dyspnea score (À2±1 versus À1±1 points, P ¼ 0.047) and quality of life (total score: þ 251±132 versus þ 84±152 points, P ¼ 0.018) after hospitalization. A significant correlation between the increase in respiratory muscle endurance and improvement in 6MWT distance was observed (r 2 ¼ 0.36, P ¼ 0.005). Conclusions: The present study indicates that RMET is feasible in obese patients and can induce significant improvement in dyspnea and exercise capacity. RMET may be a promising tool to improve functional capacity and adherence to physical activities in this population, but further studies are needed to confirm these results.
Introduction
The prevalence of obesity is increasing dramatically throughout the developed world and represents an important health concern by increasing the risk of all-cause mortality. 1 The mechanical derangements of obesity regarding the respiratory system are well established and include a reduced compliance with increased work and oxygen cost of breathing. 2, 3 During physical activity, these mechanical abnormalities are associated with increased ventilatory requirements secondary to the increased metabolic load. [4] [5] [6] A greater work of breathing implies greater activation of the respiratory muscles. Some results suggest that respiratory muscle function in obesity may be compromised by the increased load that the muscles are required to overcome, and by some reduction in their capacity. [7] [8] [9] [10] As a consequence, it has been hypothesized that obese patients may be particularly predisposed to the development of respiratory muscle fatigue during exercise. 7 Respiratory muscle fatigue in turn has been shown to be a potential mechanism underlying dyspnea 11, 12 and impaired exercise tolerance. 13 Although physical activity and exercise are important components in the prevention and treatment of obesity, many obese adults without coexisting disorders are unable to exercise due to dyspnea, on exertion. 6, 14 As a result, many do not participate in regular physical activity, exertional dyspnea being therefore not only an important clinical concern, but also an obstacle to the prevention and treatment of obesity and coexisting comorbidities. Respiratory muscle training has been shown to improve respiratory muscle performance in healthy subjects and in patients, increasing the strength and/or endurance depending on training modalities. [15] [16] [17] This effect on respiratory muscle function was shown to be greater compared with whole-body exercise training (cycling or running). 18 In addition to improving respiratory muscle capacity, respiratory muscle training has also been shown to reduce the perception of adverse respiratory sensations and to increase the exercise performance in healthy subjects [19] [20] [21] as well as in patients with impaired lung function. 15, 17, 22, 23 Whether respiratory muscle training in obese patients may also improve respiratory muscle capacity, reduce dyspnea and increase exercise tolerance remains unknown. Therefore, in the present study, we evaluated the effect of adding respiratory muscle training to a standard hospitalization program in obese subjects. We hypothesized that adding respiratory muscle training would lead to greater improvements in dyspnea, exercise tolerance and quality of life.
Methods

Subjects
In total 20 patients were included in the study. Patients' characteristics are reported in Table 1 . Inclusion criteria were (i) body mass index (BMI) 430 kg m À2 , (ii) being free of respiratory diseases (chronic obstructive pulmonary diseases, asthma and restrictive disorders other than obesity), cardiovascular diseases and diabetes, and (iii) being free of musculoskeletal disorders. In all, 6 patients were smokers and 11 patients had obstructive sleep apnea (9 of them were treated with continuous positive airway pressure). All subjects gave their written informed consent to participate.
The protocol was approved by the local ethics committee and performed according to the Declaration of Helsinki. The study identifier on ClinicalTrials.gov is NCT01026155.
Study design A total of 10 consecutive patients were included in the experimental group, that is, performing respiratory muscle endurance training (RMET group, see below). In addition, to serve as a control group (CON), 10 patients matched for age and BMI were included within the next 2 months (CON group). All patients of the present study were hospitalized in our institution to follow a low-calorie diet (70-80% of the initial daily calorie intake evaluated by a questionnaire) and a physical activity program. This consisted of supervised outdoor walking and low-intensity cycle ergometry, without specific control of the exercise intensity. In addition, the RMET group performed RMET in the form of voluntary normocapnic hyperpnea (see below). 24 with a spirometer (Dyn' R, Muret, France).
Calibration was performed before each measurement.
Respiratory muscle strength. Maximal inspiratory and expiratory mouth pressures were measured at residual volume and total lung capacity, respectively, with a portable device (Micro RPM, Micromedical Cardinal Health, Rochester, UK). Measurements were performed according to standard procedures. 25 Respiratory muscle endurance test. The respiratory muscle endurance test was performed as previously described. 25, 26 Subjects were seated and familiarized with a commercially available RMET device (SpiroTiger, Idiag, Fehraltorf, Switzerland) allowing partial rebreathing and voluntary normocapnic hyperpnea. The rebreathing bag was adjusted to 50% of the subject's VC and the test was started at a target minute ventilation . V E corresponding to 20% MVV. . V E was increased by 10% of MVV every 3 min until the subject could not maintain the target breathing frequency (f R ) and tidal Respiratory muscle training in obesity J-C Villiot-Danger et al volume (V T ). The total test duration (min) as well as the maximum ventilatory level sustained for at least 3 min (expressed as a percentage of MVV) were recorded.
6-min walking test. At least 2 hours after the respiratory muscle endurance test, to assess functional exercise capacity, subjects performed a 6MWT test in a 74-m length corridor, the best of two attempts being used for analysis, according to standard procedures. 27 Before the test, the subjects were questioned about their sensation of dyspnea and were told to indicate at the end of the test, the percentage of their effort limitation due to dyspnea, the rest of the limitation being due to other factors such as leg fatigue.
26
Questionnaires and blood measurements. Dyspnea was assessed using the MRC dyspnea scale. 28 Quality of life was assessed with the SF-36 questionnaire. 29 Fasting blood samples were drawn and serum was separated by centrifugation. Glucose, triglycerides, high-and low-density lipoprotein concentrations were assessed in serum using an automatic analyzer (Beckman Coulter, Brea, CA, USA). All measurements were performed similarly and according to the same schedule at the beginning and at the end of the hospitalization stay. The room temperature and moisture were noted during each test and confirmed the presence of equivalent conditions for all tests.
Respiratory muscle endurance training
Patients from the RMET group performed 30-min training sessions, 4 days per week with 1 day of rest between 2 days of consecutive training. RMET was performed with a commercially available respiratory endurance training device (Spiro Tiger, Idiag) allowing partial CO 2 rebreathing and thus assuring normocapnic hyperpnea. RMET consisted of voluntary normocapnic hyperpnea at a given V T and f R with a duty cycle of 0.5. The size of the rebreathing bag was set at 50% VC and . V E of the first training session was set at 50-60% MVV. The SpiroTiger provided breath-by-breath feedback of f R and V T . f R was increased from one session to another by 1-2 breaths min
À1
. All the sessions were supervised.
Data analysis
Group data are expressed as mean±s.d. To test the effect of the hospitalization period and the difference between groups, a two-way analysis of variance (analysis of variance, time Â group) was used. When significant main effects were found, Fischer's P-test was used for post hoc analysis. Relationships among the main variables were determined with Pearson's correlation coefficients. All statistical calculations were performed on standard statistical software (NCSS, Kaysville, UT, USA). The level of statistical significance was set at Po0.05.
Results
Patients' characteristics and details of the hospitalization period are reported in Table 1 . No significant difference in blood glucose, triglycerides, high-density lipoprotein cholesterol concentrations and blood pressure was observed between groups, suggesting similar metabolic and cardiovascular status. Also, smoking prevalence and presence of obstructive sleep apnea were not significantly different between groups (all P40.05).
All patients lost weight over the hospitalization period (body mass: RMET À5 ± 2%, CON À4 ± 2%; BMI:
; all Po0.05). No significant difference was observed between both groups.
In the RMET group, breathing frequency during the RMET sessions increased from 31 ± 4 cycles min À1 at the first session (leading to a ventilatory level of 56 ± 8% MVV) to 44±8 cycles min À1 at the last session (leading to a ventilatory level of 82 ± 14% MVV).
Lung function and respiratory muscles
Lung function parameters are reported in Table 2 . Values were within normal range and similar between both groups. There was no significant change after the hospitalization period, except for VC, which was significantly improved in the RMET group.
Respiratory muscle strength and endurance Respiratory muscle strength values are shown in Table 2 .
Values before hospitalization were within normal range and Respiratory muscle training in obesity J-C Villiot-Danger et al not significantly different between both groups. No change in respiratory muscle strength was observed after the hospitalization period. Breathing duration during the respiratory muscle endurance test was significantly increased after the hospitalization period in the RMET group, while no change was observed in the CON group (Figure 1) . The maximal ventilatory level sustained for at least 3 min was significantly increased after the hospitalization period in the RMET group (70 ± 18% before versus 102 ± 14% after, Po0.001), whereas no change was observed in the CON group (66±16% before versus 69±21% after, P ¼ 0.279).
Functional exercise capacity
The 6MWT distances before and after the hospitalization period are shown in Figure 2 . Values before hospitalization were 101±15 and 98±12% of the predicted values for the RMET and CON groups, respectively. 6MWT distance was significantly improved after the hospitalization period in the RMET group only. Walking distance increased on average by þ 54±35 m, while in the CON group the average difference was þ 7 ± 31 m. The percentage of effort limitation due to dyspnea was significantly reduced during the hospitalization in the RMET group (56±18% before versus 29±21% after, Po0.05), whereas it did not change significantly in the CON group (46 ± 19% before versus 45 ± 19% after, P ¼ 0.745).
Dyspnea and quality of life
The score on the MRC scale was significantly reduced after hospitalization in both the RMET and the CON groups; the reduction was however greater in the RMET group (Figure 3) . Scores of the SF-36 questionnaire before and after the hospitalization period are shown in Figure 4 for the RMET and CON groups. All domains significantly improved in the RMET group after hospitalization, whereas no significant change was observed in the CON group. The change in physical health domain only was significantly different between groups (Po0.001).
Correlation analysis
When all patients were pooled, change in 6MWT distance correlated with the change in breathing duration ( Figure 5 
Discussion
The present study evaluated for the first time in obese patients the effect of adding respiratory muscle training to a standard hospitalization program, including a low-calorie diet and a physical activity program. Although BMI was similarly reduced after the hospitalization period in both groups, the results showed that RMET increased respiratory muscle endurance, reduced perception of dyspnea, improved 6MWT and quality of life. A significant correlation was observed between the improvement in 6MWT and the improvement in respiratory muscle endurance. Hence, this study suggests that adding RMET to standard management in obese patients may be a promising tool to reduce dyspnea symptoms and increase functional capacity in this population.
Effect of RMET on lung function and respiratory muscle performances
The patients in the present study had lung function values within the normal range before hospitalization, in accordance with previous reports in a similar population. 7, 8, 30 As reported in studies including subjects with normal lung function, 19, 26, 31 small changes in lung function were observed after RMET, VC being only slightly increased. Respiratory muscle strength was also within the normal range in this obese population and did not change after RMET as previously reported in subjects with normal values. 19, 26, 31 Respiratory muscle endurance, on the other hand, was substantially increased after RMET (Figure 1 ). This improvement was observed despite normal initial endurance, as similar values were obtained in our laboratory in a group of young healthy subjects (20-35 years old, mean maximal ventilatory level: 68±10% MVV, unpublished data). This result indicates that RMET is feasible and can improve respiratory muscle endurance in obese patients as previously reported in healthy subjects and in other diseases. 19, 23, 26, 31, 32 Although obese patients are known to breath at a lower lung volume (that is, with reduced functional residual volume), increasing by RMET their respiratory muscle capacity and thus their ability to deal with the reduced respiratory system compliance might modify their distance and change in the respiratory muscle endurance test duration from before to after the hospitalization period (CON group: white symbols; RMET group: black symbols).
Respiratory muscle training in obesity J-C Villiot-Danger et al operational lung volume. The only index measured in the present study was the expiratory reserve volume at rest, which did not change in either group. This result indicates that increasing respiratory muscle endurance does not modify the operational lung volume, at least at rest. Further studies are needed to evaluate the effect of respiratory muscle training on lung volume at rest and during exercise in obese patients.
Effect of RMET on exercise tolerance and dyspnea
The average 6MWT measured in the present study is in accordance with previous reports in similar populations.
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6MWT increased after hospitalization in the RMET group only (Figure 2 ), this increase being considered as clinically significant. 34 Surprisingly, no significant change in 6MWT
was observed in the CON group, suggesting that the standard hospitalization program induced significant weight loss but no obvious improvement in exercise tolerance. The improvement in exercise capacity after RMET is in accordance with previous studies showing that RMET can increase exercise performance both in healthy subjects 35 and in patients. 23 Interestingly, a significant correlation was observed between the improvements in 6MWT and duration of the respiratory muscle endurance test ( Figure 5 ), suggesting that an increase in respiratory muscle function may have a critical role for improving functional capacity of obese patients. Potential mechanisms in exercise performance are a reduction in exercise-induced respiratory muscle fatigue 31 and/or a reduction in adverse respiratory symptoms. 35 In obese patients, the increased work of breathing may accelerate exercise-induced respiratory muscle fatigue 7 and promote dyspnea. 36 Hence, RMET may prevent respiratory muscle fatigue and subsequently dyspnea during exercise in obese patients, therefore improving the exercise performance. Although respiratory muscle fatigue was not evaluated in the present study, subjects reported less effort limitation due to dyspnea after RMET, suggesting that RMET may indeed improve exercise tolerance in obese patients by reducing dyspnea. Also confirming that RMET improved dyspnea symptoms, the MRC scale indicated greater reduction in dyspnea when adding RMET to the standard hospitalization program (Figure 3 ). The significant correlations observed between the improvement in respiratory muscle endurance and the reduction in perception of dyspnea also suggest that increased respiratory muscle function may translate into reduced dyspnea among obese patients. The improved perception of dyspnea after respiratory muscle training might be the consequence of an increase resistance to respiratory muscle fatigue 31 and/or a reduction in the respiratory motor outflow required to generate a given inspiratory/expiratory pressure. 11, 36 No significant correlation was observed between changes in exercise performance and perception of dyspnea. Finally, the RMET group had a significant improvement in SF-36 score after the hospitalization period in all domains.
The significant correlation between the increase in respiratory muscle endurance and the change in the physical health domain of the SF-36 questionnaire suggests that the improvement in respiratory muscle function may underlie, at least in part, the improvement in quality of life. Hence, improvement in respiratory muscle capacity, dyspnea and exercise tolerance following RMET may translate into a better quality of life in obese patients. Dreher et al. 37 recently showed that proportional assist ventilation can increase exercise capacity in obese patients. These results emphasize the role of respiratory muscle work as a factor contributing to exercise limitation in these patients. In addition, this study indicated that all patients did not respond similarly to proportional assist ventilation during exercise: a post hoc analysis showed that 10 out of 18 patients could be considered as responders (increasing exercise endurance by more than 20%) and were characterized by lower lung volume. In the present study, no relationship was observed between the effect of RMET and the initial lung function, respiratory muscle capacities (strength or endurance), dyspnea level or exercise capacity. Therefore, although it would be critical to know which patients are susceptible to improve the most with RMET, the present study cannot distinguish between responders and non-responders, and can neither provide predictive factors regarding the effect of RMET as suggested in other patient populations (for example, respiratory muscle weakness in chronic obstructive pulmonary disease).
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Limitations of the study Although the present study is the first to have investigated the effect of respiratory muscle training in obese patients, we nevertheless acknowledge some study limitations. Our sample size was limited and no sham respiratory muscle training was used. A matched CON group having followed the same hospitalization program without RMET was, however, included and compared with 10 consecutive patients having performed RMET. These CON patients were not aware of the specific management of the RMET group as RMET sessions were performed individually in the patient's bedroom and as CON and RMET patients were not included simultaneously. Patients in both groups were not matched for gender, leading to more females in the CON group than in the RMET group. The difference was, however, not significant and no difference in respiratory muscle fatigue has been shown between males and females. 39 Also, as indicated above, studies with larger sample size are needed in order to identify predictive factors to select the patients who should benefit the most from RMET, as in practice it might not be possible to offer such a management to all patients. At last, we evaluated the effect of RMET as a tool to improve inspiratory and expiratory muscle function under conditions similar to exercise-induced hyperpnea, 40 but inspiratory muscle resistive training could also be tested as a tool to specifically improve inspiratory muscle strength and
Respiratory muscle training in obesity J-C Villiot-Danger et al compared with RMET. 41 Hence, further large clinical randomized trials, including sham respiratory muscle training and/or other conventional rehabilitation modalities, are required to confirm and generalize these promising findings.
In conclusion, the present study indicates that RMET is feasible and increases respiratory muscle endurance in obese patients. In addition, when added to a standard low-calorie diet and physical activity program, it can reduce the perception of dyspnea, improve exercise performance and the quality of life. Therefore, in the context of exertional dyspnea being considered as an obstacle to the prevention and treatment of obesity and coexisting comorbidities, RMET may be a promising tool to improve functional capacity and adherence to physical activities. Further studies are, however, needed to clarify the effects and the best modalities of respiratory muscle training in obese patients.
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